Invention Grant
- Patent Title: KAT II inhibitors
- Patent Title (中): KAT II抑制剂
-
Application No.: US14068707Application Date: 2013-10-31
-
Publication No.: US08933095B2Publication Date: 2015-01-13
- Inventor: Amy Beth Dounay , Laura Ann McAllister , Vinod Dipak Parikh , Suobao Rong , Patrick Robert Verhoest
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Feng Shao
- Main IPC: C07D235/02
- IPC: C07D235/02 ; C07D403/00 ; C07D231/56 ; C07D487/00 ; C07D471/04 ; C07D487/04
Abstract:
Compounds of Formula I: wherein X, Y, Z, R1, R2, R3, R4 are as defined herein, and pharmaceutically acceptable salts thereof, are described as useful for the treatment of cognitive deficits associated with schizophrenia and other psychiatric, neurodegenerative and/or neurological disorders in mammals, including humans.
Public/Granted literature
- US20140057938A1 KAT ll INHIBITORS Public/Granted day:2014-02-27
Information query
